So honoured to have been part of the PACE team for the last 12 years. I have learned so much from @nickva1 @EmmaHall71 and the whole team. Thanks to the 874 men and over 30 hospitals who partnered with us and to Accuray for funding. Abstract here astro2023.eventscribe.net/index.asp?sessโฆ
Alison Tree ๐
2,730 posts
- In a world desperate for some good news, I am so proud to congratulate the awesome @AnnaKirby17 @royalmarsdenNHS @ICR_London on becoming President Elect of @ESTRO_RT Shame we can't all raise a glass in person, but hopefully soon...
- My first Tweetorial ๐งต 2 year toxicity results of PACE B published here. Big thanks to the ๐ฌ๐ง๐จ๐ฆ and๐ฎ๐ชcollaborators and the 874 men with prostate cancer who made this trial possible
- PACE-B 2 year paper finally out! thelancet.com/journals/lanonโฆ Tweetorial coming shortly, but firstly massive thanks to @nickva1 @EmmaHall71 @royalmarsdenNHS @royalmarsden @Accuray @VarianMedSys @ICR_CTSU @ProstateUK and many more, for support of the PACE umbrella
- One tiny silver lining of this tragedy is that, at present, winning Love Island is no longer seen as the pinnacle of achievement in the world, but instead people seem to value kindness, caring for others and bravery. Letโs hope that lasts.
- Despite another trying year, good to see our sense of humour is intact in the @RM_Radiotherapy Christmas decoration competition. Glad I don't need to choose between the Penguin Cyberknife and the MR Linac igloo! It is truly a privilege to work with you all. Merry Christmas.
- Oligoprogression: Treat the whole lawn or weed selectively? clinicaloncologyonline.net/article/S0936-โฆ @drdavidpalma @fifimcdrmh @RCRadiologists Lots of exciting research ongoing including the TRAP trial (thanks to @ProstateUK) and the HALT trial (thanks to @CR_UK @ICR_CTSU)
- #PACE A showing more urinary incontinence than expected #GU23 Great presentation โฆ@nickva1โฉ and credit to whole team โฆ@royalmarsdenNHSโฉ โฆ@ICR_CTSUโฉ for running such a difficult trial
- A real honour to visit Tata Memorial hospital and to attend the SOGOCON23 conference, meeting many multi-disciplinary colleagues committed to improving uro-oncological care in India. And they are running so many amazing trials!
- Delighted that the first DELINEATE trial cohorts now published @IJROBP . 5yr bRFS 96.7% with boost to 67Gy in 20; toxicity similar to non-boost literature. Thanks to Prof Dearnaley who set this trial up in 2011! authors.elsevier.com/a/1fxC61Hx52CNโฆ @juliarmurray @PCaParker @RM_Radiotherapy
- Shocking! Only 1.4% of global cancer spend is used for surgical research and only 2.8% on radiotherapy research. Please help us learn how to cure more patients by funding curative therapies research! #radoncThe abysmal state of global research funding on key domains such as surgery, radiotherapy and health services. Combined less than 4%. How have research funding organisations managed to get their strategic priorities so wrong? โฆ@csprameshโฉ โฆ thelancet.com/journals/lanonโฆ
- Great to see long term results from OLIGOPELVIS, seems likely that cure is a realistic option for some patients (maybe 1/3rd) with pelvic oligorecurrence #ESTRO23
- Delighted that we have achieved our accrual target for the TRAP trial this week clinicaltrials.gov/ct2/show/NCT03โฆ funded by the amazing people @ProstateUK . Thanks to so many people who made this happen during a really tough few years! @RTTQA_UK @royalmarsdenNHS

















